4
Changes in Ownership
Solid Biosciences Inc. Filed Acc 0000950170-25-022201
Chief Technology Officer sold 2,688 shares at $3.96 ($10,644)
- Chief Technology Officer acquired 7,187 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Herzich Paul Chief Technology Officer | 2025-02-13 | Option exercise 10b5-1 | +7,187 | 21,076 | D | ||
| Herzich Paul Chief Technology Officer | 2025-02-14 | Sale 10b5-1 | −2,688 | $3.96 | $10,644 | 18,388 | D |
| Derivatives | |||||||
| Herzich Paul Chief Technology Officer | 2025-02-13 | Option exercise · Restricted Stock Units 10b5-1 | −7,187 | 21,563 | D | ||
| Open-market sales · 2,688 sh · avg $3.96 · $10,644 | |||||||
Loading xslF345X05/ownership.xml…